Agency Forms Undergoing Paperwork Reduction Act Review, 70830-70831 [2022-25243]
Download as PDF
<![CDATA[
70830
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–25245 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–23–0010]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Birth Defects
Study To Evaluate Pregnancy exposureS
(BD–STEPS)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on March 1,
2022 to obtain comments from the
public and affected agencies. CDC
received two comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street, NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Birth Defects Study To Evaluate
Pregnancy exposureS (BD–STEPS)
(OMB Control No. 0920–0010, Exp. 2/
28/2023)—Revision—National Center
on Birth Defects and Developmental
Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Birth defects are associated with
substantial morbidity and mortality in
the United States. About one in every 33
babies is born with a birth defect. Birth
defects contributed to more than one
million hospital stays in the U.S. in
2013, resulting in $22.9 billion in
hospital costs. Birth defects are the
leading cause of infant mortality and the
fifth leading cause of loss of potential
years of life before age 65. One in five
infant deaths is due to birth defects.
For most birth defects, the causes are
not known, making prevention efforts
challenging to develop. To date, primary
preventive measures are available for
only a few birth defects. For example,
vaccination programs have reduced the
incidence of congenital rubella
syndrome, Rh hemolytic disease of the
newborn can be prevented by
appropriate medical practice, and
genetic counseling can provide parents
with information about the increased
risk of Down syndrome associated with
advanced maternal age. Perhaps most
importantly, folic acid intake before and
during pregnancy can prevent many
cases of fatal or permanently disabling
neural tube defects such as anencephaly
and spina bifida.
This continued burden justifies
reasonable attempts to reduce the
prevalence of birth defects. To help
reduce birth defects among U.S. babies,
in 1996 Congress directed the CDC to
establish Centers of Excellence for Birth
Defects Research and Prevention. The
mandate was formalized with passage of
the Birth Defects Prevention Act of
1998. This Act amended Section 317C
of the Public Health Service Act (42
U.S.C. 247b–4) and authorized CDC to:
(1) collect, analyze, and make available
data on birth defects; (2) operate
regional centers that will conduct
applied epidemiological research for the
prevention of birth defects; and (3)
provide the public with information on
preventing birth defects.
In response to this mandate, the
Division of Birth Defects and Infant
Disorders (DBDID) obtained OMB
clearance for data collection that is
carried out by the Centers for Birth
Defects Research and Prevention
(CBDRP). The CBDRP’s first research
effort was the National Birth Defects
Prevention Study (NBDPS), which
began data collection in 1997 and ended
in 2013. The CBDRPs transitioned from
NBDPS to the Birth Defects Study To
Evaluate Pregnancy exposureS (BD–
STEPS), which began data collection in
2014. One of the main activities for each
Center is to conduct BD–STEPS in their
state, and the purpose of BD–STEPS is
to evaluate factors associated with the
occurrence of birth defects and
stillbirths, and ultimately to work to
prevent major birth defects and
stillbirths associated with maternal risk
factors.
CDC requests OMB approval for an
estimated 4,473 annual burden hours.
There is no cost to respondents other
than their time to participate.
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Mothers (Interview) ................
VerDate Sep<11>2014
21:25 Nov 18, 2022
Number of
respondents
Form name
Core Computer Assisted
Telephone Interview.
Jkt 259001
PO 00000
Frm 00061
3,030 ......................................
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Number of
responses per
respondent
E:\FR\FM\21NON1.SGM
1
21NON1
55/60
70831
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Mothers (Consent) .................
Linkage to Reportable Infectious Disease Consent.
Residual Newborn Bloodspot
Consent.
2,590 ......................................
1
15/60
1,850 ......................................
1
15/60
Online Occupational Questionnaire.
Supplemental Computer Assisted Telephone Interview.
Authorization Form for Stillbirth COVID–19 Sub-Study.
830 .........................................
1
20/60
640 .........................................
1
25/60
157 .........................................
1
15/60
Mothers (Consent for Residual Newborn Bloodspot Retrieval).
Mothers (Online Questionnaire).
Mothers of AR/MA Stillbirths
and Controls (Interview).
Mothers of AR/MA Stillbirths
with Specimens available
for Testing.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–25243 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–22FT]
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSK11XQN23PROD with NOTICES1
Average
burden per
response
(in hours)
Number of
responses per
respondent
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Enhanced
Surveillance of Respiratory Illness
Among People Experiencing
Homelessness in Anchorage, Alaska’’ to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on June 2, 2022 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Proposed Project
Enhanced Surveillance of Respiratory
Illness Among People Experiencing
Homelessness in Anchorage, Alaska—
New—National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
People experiencing homelessness are
at higher risk for respiratory infectious
diseases. However, the causes of these
infections are not well understood. This
project involves enhanced surveillance
for organisms that cause respiratory
illness in congregate and non-congregate
homeless shelters to provide evidence to
improve public health for people who
are experiencing homelessness in
Anchorage, Alaska.
The project team will collect an upper
respiratory specimen (e.g.,
nasopharyngeal swab) from people
experiencing respiratory symptoms who
are accessing shelters. A member from
the project team will complete
demographic questions and a short
symptom questionnaire with the
participant. Swabs obtained from study
participants will be tested for multiple
respiratory pathogens to: (1) estimate
the burden of pathogen-specific
respiratory infections among people
experiencing homelessness; (2) inform
infection control; and (3) determine the
vaccination status of people in this
population.
CDC requests OMB approval for an
estimated 500 annual burden hours for
this collection. There is no cost to
respondents other than their time to
participate.
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Pages 70830-70831]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25243]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-23-0010]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Birth Defects Study To Evaluate Pregnancy
exposureS (BD-STEPS)'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
March 1, 2022 to obtain comments from the public and affected agencies.
CDC received two comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street, NW, Washington, DC 20503 or by fax to
(202) 395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) (OMB
Control No. 0920-0010, Exp. 2/28/2023)--Revision--National Center on
Birth Defects and Developmental Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Birth defects are associated with substantial morbidity and
mortality in the United States. About one in every 33 babies is born
with a birth defect. Birth defects contributed to more than one million
hospital stays in the U.S. in 2013, resulting in $22.9 billion in
hospital costs. Birth defects are the leading cause of infant mortality
and the fifth leading cause of loss of potential years of life before
age 65. One in five infant deaths is due to birth defects.
For most birth defects, the causes are not known, making prevention
efforts challenging to develop. To date, primary preventive measures
are available for only a few birth defects. For example, vaccination
programs have reduced the incidence of congenital rubella syndrome, Rh
hemolytic disease of the newborn can be prevented by appropriate
medical practice, and genetic counseling can provide parents with
information about the increased risk of Down syndrome associated with
advanced maternal age. Perhaps most importantly, folic acid intake
before and during pregnancy can prevent many cases of fatal or
permanently disabling neural tube defects such as anencephaly and spina
bifida.
This continued burden justifies reasonable attempts to reduce the
prevalence of birth defects. To help reduce birth defects among U.S.
babies, in 1996 Congress directed the CDC to establish Centers of
Excellence for Birth Defects Research and Prevention. The mandate was
formalized with passage of the Birth Defects Prevention Act of 1998.
This Act amended Section 317C of the Public Health Service Act (42
U.S.C. 247b-4) and authorized CDC to: (1) collect, analyze, and make
available data on birth defects; (2) operate regional centers that will
conduct applied epidemiological research for the prevention of birth
defects; and (3) provide the public with information on preventing
birth defects.
In response to this mandate, the Division of Birth Defects and
Infant Disorders (DBDID) obtained OMB clearance for data collection
that is carried out by the Centers for Birth Defects Research and
Prevention (CBDRP). The CBDRP's first research effort was the National
Birth Defects Prevention Study (NBDPS), which began data collection in
1997 and ended in 2013. The CBDRPs transitioned from NBDPS to the Birth
Defects Study To Evaluate Pregnancy exposureS (BD-STEPS), which began
data collection in 2014. One of the main activities for each Center is
to conduct BD-STEPS in their state, and the purpose of BD-STEPS is to
evaluate factors associated with the occurrence of birth defects and
stillbirths, and ultimately to work to prevent major birth defects and
stillbirths associated with maternal risk factors.
CDC requests OMB approval for an estimated 4,473 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondents Form name Number of responses per Average burden per
respondents respondent response (in hours)
----------------------------------------------------------------------------------------------------------------
Mothers (Interview).............. Core Computer 3,030.............. 1 55/60
Assisted Telephone
Interview.
[[Page 70831]]
Mothers (Consent)................ Linkage to 2,590.............. 1 15/60
Reportable
Infectious Disease
Consent.
Mothers (Consent for Residual Residual Newborn 1,850.............. 1 15/60
Newborn Bloodspot Retrieval). Bloodspot Consent.
Mothers (Online Questionnaire)... Online Occupational 830................ 1 20/60
Questionnaire.
Mothers of AR/MA Stillbirths and Supplemental 640................ 1 25/60
Controls (Interview). Computer Assisted
Telephone
Interview.
Mothers of AR/MA Stillbirths with Authorization Form 157................ 1 15/60
Specimens available for Testing. for Stillbirth
COVID-19 Sub-Study.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-25243 Filed 11-18-22; 8:45 am]
BILLING CODE 4163-18-P
